Health Care: Drugs

Array BioPharma Inc (ARRY: NASDAQ)

$3.76 -0.03 | -0.79%
09/19/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 3.79
52 Week High 6.66
52 Week Low 3.39
Avg. Daily Vol. (Mil) 1.43
Beta (3 year) 2.60
Share Related Items
Mkt Cap (Mil) 499.63
Shares Out (Mil) 131.82
Float (Mil) 103.05
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.20
Current Ratio 2.30
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 11.87
Price/Book 0.00
Price/Cash Flow -6.20
Per Share Data
Earnings -0.69
Sales 0.32
Book Value 0.00
Cash Flow -0.61
Business Summary
Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.
General Information
3200 Walnut Street
Boulder, CO 80301
www.arraybiopharma.com
Industry : Drugs
Sector: Health Care
Employees: 198
CEO: Ron Squarer
Short Interest
Current Month (Mil) 18.73
Previous Month (Mil) 18.56
Short Interest Ratio (Days) 18.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -61.30
Return on Investments -109.00
Profitability
Gross Margin 1.50
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ARRY

Latest ARRY Headlines from TheStreet

More Financial News for ARRY

Press Releases for ARRY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter